Overview
Emily Berry is a Gynecologic Oncologist and an Oncologist in Bend, Oregon. Dr. Berry is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, and Malignant Mixed Mullerian Tumor. Dr. Berry is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- PPO
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2500 Ne Neff Rd, Bend, OR 97701
211 Nw Larch Ave, Family Care, Redmond, OR 97756
Bend Memorial Clinic PC
William Schmidt is a Hematologist Oncology specialist and an Oncologist in Bend, Oregon. Dr. Schmidt is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Testicular Yolk Sac Tumor, and Virilizing Ovarian Tumor. Dr. Schmidt is currently accepting new patients.
St Charles Health System Inc
Natasha Tiffany is a Hematologist Oncology specialist and a Hematologist in Redmond, Oregon. Dr. Tiffany is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Dehydration, HER-2 Positive Breast Cancer, and Bone Marrow Aspiration. Dr. Tiffany is currently accepting new patients.
St Charles Health System Inc
William Martin is an Oncologist and a Hematologist in Redmond, Oregon. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Systemic Mastocytosis, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Martin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Endometrial CancerDr. Berry isDistinguished. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Berry isDistinguished. Learn about Endometrial Stromal Sarcoma.
- Malignant Mixed Mullerian TumorDr. Berry isDistinguished. Learn about Malignant Mixed Mullerian Tumor.
- Ovarian CarcinosarcomaDr. Berry isDistinguished. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Berry isDistinguished. Learn about Sertoli-Leydig Cell Tumor.
- Advanced
- Adult Soft Tissue SarcomaDr. Berry isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Desmoplastic Small Round Cell Tumor
- EndometritisDr. Berry isAdvanced. Learn about Endometritis.
- MelanomaDr. Berry isAdvanced. Learn about Melanoma.
- Ovarian CancerDr. Berry isAdvanced. Learn about Ovarian Cancer.
- Testicular Yolk Sac TumorDr. Berry isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Experienced
- AdenomyosisDr. Berry isExperienced. Learn about Adenomyosis.
- BRCA Positive Breast CancerDr. Berry isExperienced. Learn about BRCA Positive Breast Cancer.
- Cervical CancerDr. Berry isExperienced. Learn about Cervical Cancer.
- Cervical DysplasiaDr. Berry isExperienced. Learn about Cervical Dysplasia.
- DICER1 SyndromeDr. Berry isExperienced. Learn about DICER1 Syndrome.
- HER2 Negative Breast CancerDr. Berry isExperienced. Learn about HER2 Negative Breast Cancer.